Literature DB >> 21989830

In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein.

Vidya Rajendran1, Rituraj Purohit, Rao Sethumadhavan.   

Abstract

Lamin A/C proteins are the major components of a thin proteinaceous filamentous meshwork, the lamina, that underlies the inner nuclear membrane. A few specific mutations in the lamin A/C gene cause a disease with remarkably different clinical features: FPLD, or familial partial lipodystrophy (Dunnigan-type), which mainly affects adipose tissue. Lamin A/C mutant R482W is the key variant that causes FPLD. Biomolecular interaction and molecular dynamics (MD) simulation analysis were performed to understand dynamic behavior of native and mutant structures at atomic level. Mutant lamin A/C (R482W) showed more interaction with its biological partners due to its expansion of interaction surface and flexible nature of binding residues than native lamin A/C. MD simulation clearly indicates that the flexibility of interacting residues of mutant are mainly due to less involvement in formation of inter and intramolecular hydrogen bonds. Our analysis of native and Mutant lamin A/C clearly shows that the structural and functional consequences of the mutation R482W causes FPLD. Because of the pivotal role of lamin A/C in maintaining dynamics of nuclear function, these differences likely contribute to or represent novel mechanisms in laminopathy development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989830     DOI: 10.1007/s00726-011-1108-7

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  43 in total

1.  Novel Insights for Inhibiting Mutant Heterodimer IDH1wt-R132H in Cancer: An In-Silico Approach.

Authors:  Ezequiel Iván Juritz; Juan Pablo Bascur; Daniel Eduardo Almonacid; Fernando Danilo González-Nilo
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.074

2.  On human disease-causing amino acid variants: statistical study of sequence and structural patterns.

Authors:  Marharyta Petukh; Tugba G Kucukkal; Emil Alexov
Journal:  Hum Mutat       Date:  2015-04-06       Impact factor: 4.878

3.  Designing a less immunogenic nattokinase from Bacillus subtilis subsp. natto: a computational mutagenesis.

Authors:  Yoanes Maria Vianney; Stanley Evander Emeltan Tjoa; Reza Aditama; Sulisyto Emantoko Dwi Putra
Journal:  J Mol Model       Date:  2019-11-09       Impact factor: 1.810

4.  A molecular dynamics approach to explore the structural characterization of cataract causing mutation R58H on human γD crystallin.

Authors:  Rohini Karunakaran; P S Srikumar
Journal:  Mol Cell Biochem       Date:  2018-03-12       Impact factor: 3.396

5.  Single nucleotide polymorphisms in microRNA binding sites of oncogenes: implications in cancer and pharmacogenomics.

Authors:  Mayakannan Manikandan; Arasambattu Kannan Munirajan
Journal:  OMICS       Date:  2013-11-28

6.  Impact of point mutation P29S in RAC1 on tumorigenesis.

Authors:  Vidya Rajendran; Chandrasekhar Gopalakrishnan; Rituraj Purohit
Journal:  Tumour Biol       Date:  2016-10-03

7.  Computational investigation of molecular mechanism and neuropathological implications in Huntington disease.

Authors:  Chandrasekhar Gopalakrishnan; Namrata Kalsi; Shraddha Jethi; Rituraj Purohit
Journal:  Mol Cell Biochem       Date:  2015-09-14       Impact factor: 3.396

8.  In silico approach to explore the disruption in the molecular mechanism of human hyaluronidase 1 by mutant E268K that directs Natowicz syndrome.

Authors:  D Meshach Paul; R Rajasekaran
Journal:  Eur Biophys J       Date:  2016-07-16       Impact factor: 1.733

Review 9.  Broken nuclei--lamins, nuclear mechanics, and disease.

Authors:  Patricia M Davidson; Jan Lammerding
Journal:  Trends Cell Biol       Date:  2013-12-02       Impact factor: 20.808

10.  In-silico screening of cancer associated mutation on PLK1 protein and its structural consequences.

Authors:  Balu Kamaraj; Vidya Rajendran; Rao Sethumadhavan; Rituraj Purohit
Journal:  J Mol Model       Date:  2013-11-23       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.